Perinatal outcomes and sinopharm BBIBP-CorV vaccination during pregnancy
Abstract Background After the outbreak of COVID-19, a huge part of the health care services was dedicated to preventing and treating this disease. In case of COVID-19 infection, severe COVID-19 is reported more in pregnant individuals. Afterward, Vaccination against SARS-CoV-2 became a hot topic due...
Saved in:
Main Authors: | Donya Hatami (Author), Abbas Habibelahi (Author), Nasrin Changizi (Author), Mohammad Heidarzadeh (Author), Marzieh Nojomi (Author), Moein Rast (Author), Kiarash Ansari (Author), Arash Tehrani‐Banihashemi (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2024-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antibody responses to Sinopharm/BBIBP-CorV in pregnant mothers in Sri Lanka.
by: Chandima Jeewandara, et al.
Published: (2022) -
Antibody responses to Sinopharm/BBIBP-CorV in pregnant mothers in Sri Lanka
by: Chandima Jeewandara, et al.
Published: (2022) -
Real-world study of the effectiveness of BBIBP-CorV (Sinopharm) COVID-19 vaccine in the Kingdom of Morocco
by: Yaowen Zhang, et al.
Published: (2022) -
SG-APSIC1049: Immunogenicity of Gam-COVID-Vac and Sinopharm BBIBP-CorV vaccines in seropositive and seronegative adults
by: Igor Stoma, et al.
Published: (2023) -
Self-Reported safety of the BBIBP-CorV (Sinopharm) COVID-19 vaccine among Iranian people with multiple sclerosis
by: Masoud Etemadifar, et al.
Published: (2022)